Beyond in vitro studies, mice injected with SR-BI-knockdown breast cancer cells showed a decreased tumor burden, accompanied with reduced Akt and ERK1/2 activation, reduced angiogenesis, and increased apoptosis [86]. The gene discussed is SCARB1; the disease is breast cancer.